AMC Global’s latest research with OpinionRoute explores how GLP-1 weight loss drugs, including Ozempic and Wegovy, are transforming consumer food and beverage habits. The findings highlight significant opportunities for food brands to innovate—addressing the unique needs of this growing segment. These insights are essential for understanding the evolving preferences shaping the marketplace.
The first wave of the study, “Impact of GLP-1 Weight Loss Drugs on Food Choices,” revealed that GLP-1 medication users, a quickly growing segment of the population, are undergoing significant shifts in their food choices. As these consumers embrace healthier habits, they are seeking smaller portion sizes, nutrient-rich foods—and products offering functional benefits like fiber and protein. This trend presents an opportunity for food brands to innovate and meet the evolving demands of this group, including products that cater to smaller pack sizes and added nutritional value. The study underscores the growing importance of understanding these changing consumer behaviors. You can view more here: https://news.amcglobal.com/impact-of-glp-1-weight-loss-drugs-on-food-choices
The second wave of the study, “Food & Beverage Products Sought by GLP-1 Users,” reveals a strong demand among users for food and beverage products tailored to their needs. GLP-1 users are increasingly seeking foods rich in protein, fiber and functional benefits like antioxidants and omega-3s. Popular items include yogurt, cheese, red meat, fresh fruit and protein bars. With a growing preference for smaller portion sizes, this presents an opportunity for brands to innovate and meet the evolving needs of this consumer group. You can view more here: https://news.amcglobal.com/top-products-sought-by-glp1-medication-users
